On September 20th, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) will jointly host a public meeting titled "Advancing the End of Tobacco Addiction: FDA and NIH Priorities" on October 21st from 9:00 am to 4:30 pm. The purpose of this meeting is to promote innovation in smoking cessation products to assist adults and adolescents in quitting smoking.
The conference will feature multiple speeches and panel discussions on smoking cessation. Topics of discussion will include perspectives from clinical and community settings, promising areas for development targets, and future regulatory pathways. Additionally, the conference will provide an opportunity for open commentary, allowing the public to voice opinions on various related topics.
This conference is open to the public free of charge. It is worth noting that in-person participation requires registration by October 15, 2024, and virtual attendance can be registered by 9 a.m. (EDT) on the day of the conference. If you wish to speak during the public comment session in person, registration must be completed by 5 p.m. (EDT) on October 1st.
Written reviews must be submitted by November 21, 2024 through the Regulations.gov public docket archive [Docket No. FDA-2024-N-4085].
The U.S. Department of Health and Human Services (HHS) support and accelerate smoking cessation framework clearly outlines the goal of promoting continued and innovative research on smoking cessation. The agency stated that the joint FDA and NIH meeting in October was specifically to support these efforts, aimed at driving a collective effort across society to improve the nation's health.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
